Biomarker News and Research

RSS

A biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition. Also called molecular marker and signature molecule.

Research reveals molecular clues associated with traumatic brain injury

New research led by scientists at Arizona State University has revealed some of the first detailed molecular clues associated with one of the leading causes of death and disability, a condition known as traumatic brain injury (TBI).

23 Jul 2022

UMass Amherst scientist to study how embryonic exposure to pollutants may increase diabetes risk

A University of Massachusetts Amherst environmental health scientist has received a $2.44 million, five-year grant renewal from the National Institutes of Health to continue her research into how embryonic exposure to certain common pollutants may put people at risk for diabetes and other metabolic health conditions later in life.

22 Jul 2022

Researchers discover a ‘weak spot’ that makes multi-drug resistant tumors vulnerable

One of the greatest challenges facing cancer researchers is to understand why some patients don't respond to treatments.

22 Jul 2022

Study may help overcome some obstacles to the development of nanoparticle-based drugs

Using nanoparticles to deliver cancer drugs offers a way to hit tumors with large doses of drugs while avoiding the harmful side effects that often come with chemotherapy.

21 Jul 2022

Alzheimer's disease and anti-amyloid therapeutic approaches

An estimated 50 million people around the world have Alzheimer's disease (AD), and perhaps twice that number are unknowingly "incubating" the disease during its long presymptomatic period.

21 Jul 2022

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

A sensor identifies misfolded protein biomarkers in the blood. This offers a chance to detect Alzheimer's disease before any symptoms occur. Researchers intend to bring it to market maturity.

21 Jul 2022

Researchers report genomic profiling from more than 110,000 tumors

Researchers analyzed data from the latest public release of the GENIE project of the American Association for Cancer Research.

19 Jul 2022

Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Patients hospitalized with COVID-19 with high estimated blood viscosity are at higher risk of death from complications. High blood viscosity impairs flow to small vessels and increases the risk of blood clots. This measure of blood thickness can be used as a predictor of mortality.

18 Jul 2022

Study describes biochemical pathway that leads to inflammation characteristic of autoimmune diseases

Mitochondria are self-contained organelles (they possess their own mini-chromosome and DNA) residing within cells and are charged with the job of generating the chemical energy needed to fuel functions essential to life and well-being.

13 Jul 2022

New underlying cause of Wiskott-Aldrich syndrome discovered

Researchers at the Salk Institute and King Abdullah University of Science and Technology (KAUST) in Saudi Arabia have discovered a new underlying cause of Wiskott-Aldrich syndrome, a rare genetic disease that leads to bleeding and immune deficiencies in babies.

13 Jul 2022

Long covid patients travel abroad seeking for unproven "blood-washing" treatment

Thousands of people experiencing the debilitating symptoms of long covid are traveling abroad to seek costly but unproven treatments such as "blood washing", according to an investigation carried out by The BMJ and ITV News released today.

13 Jul 2022

Scientists determine the binding affinity of anti-SARS-CoV-2 antibodies in response to infection or vaccination

Scientists measured the quantity and binding affinity (avidity) of antibodies against five different viral proteins.

12 Jul 2022

Study examines the use of eye movements as a biomarker for dual-diagnosis of traumatic spinal cord and brain injury

Silvana Costa, PhD, of Kessler Foundation received a two-year $199,800 grant from the New Jersey Commission on Spinal Cord Research.

11 Jul 2022

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Kidney cancer accounts for only 4% of all cancers in the United States; however, its incidence has more than doubled since 1975, with the most common type being clear cell renal cell carcinoma.

8 Jul 2022

Running faster and dreaming help your left brain and right brain to communicate better

You’re out jogging and suddenly notice a low-hanging tree branch in your path. You quickly lower your head, narrowly avoiding the branch, and continue on the run without giving it another thought.

6 Jul 2022

What role does human microbiota play in COVID-19 severity?

In a recent study published in the journal Advanced Science, researchers explored the dynamic changes in the respiratory tract and gut microbiota in coronavirus disease 2019 (COVID-19) patients. They observed and analyzed these changes during different disease progression stages among patients with differential disease severities.

5 Jul 2022

Innovative strategy for treating non-small cell lung cancer when radiotherapy fails

Lung cancer is the most common cancer in the world, with 2.2 million new cases and around 1.8 million deaths in 2020 alone.

4 Jul 2022

Bladder cancer patients with ctDNA positivity respond very well to treatment with atezolizumab

Researchers who treated a group of post-surgery bladder cancer patients with the immunotherapy drug atezolizumab have found that patients whose blood contained circulating tumour DNA (ctDNA), responded very well to the treatment.

3 Jul 2022

Portable biosensor device for early detection of chronic kidney disease

A new method for early detection of chronic kidney disease, which affects an estimated 7% of the world’s population, has been shown to have potential to service rural and remote patients and communities with limited medical services.

1 Jul 2022

Researchers fabricate highly-sensitive SERS probes to detect the PD-L1 biomarker

Recently, a team led by Prof. Huang Qing at the Institute of Intelligent Machines, Hefei Institutes of Physical Science (HFIPS) of Chinese Academy of Sciences (CAS) have reported the fabrication of ultrasensitive biosensors based on Surface-enhanced Raman Spectroscopy (SERS) to detect the cancer metastasis related programmed death ligand (PD-L1) biomarker.

1 Jul 2022

Biomarker News and Research

Further Reading

Research reveals molecular clues associated with traumatic brain injury

UMass Amherst scientist to study how embryonic exposure to pollutants may increase diabetes risk

Researchers discover a ‘weak spot’ that makes multi-drug resistant tumors vulnerable

Study may help overcome some obstacles to the development of nanoparticle-based drugs

Alzheimer's disease and anti-amyloid therapeutic approaches

Immuno-infrared sensor identifies Alzheimer's disease in the blood up to 17 years in advance

Researchers report genomic profiling from more than 110,000 tumors

Hospitalized COVID-19 patients with high blood viscosity have greater risk of death

Study describes biochemical pathway that leads to inflammation characteristic of autoimmune diseases

New underlying cause of Wiskott-Aldrich syndrome discovered

Long covid patients travel abroad seeking for unproven "blood-washing" treatment

Scientists determine the binding affinity of anti-SARS-CoV-2 antibodies in response to infection or vaccination

Study examines the use of eye movements as a biomarker for dual-diagnosis of traumatic spinal cord and brain injury

Moffitt researchers discover kidney cancer-specific splicing variant biomarkers

Running faster and dreaming help your left brain and right brain to communicate better

What role does human microbiota play in COVID-19 severity?

Innovative strategy for treating non-small cell lung cancer when radiotherapy fails

Bladder cancer patients with ctDNA positivity respond very well to treatment with atezolizumab

Portable biosensor device for early detection of chronic kidney disease

Researchers fabricate highly-sensitive SERS probes to detect the PD-L1 biomarker

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo